
Heska Corporation – NASDAQ:HSKA
Heska stock price monthly change
Heska stock price quarterly change
Heska stock price yearly change
Heska key metrics
Market Cap | 1.30B |
Enterprise value | 1.16B |
P/E | -60.79 |
EV/Sales | 4.52 |
EV/EBITDA | -208.17 |
Price/Sales | 4.73 |
Price/Book | 2.88 |
PEG ratio | 0.03 |
EPS | -1.78 |
Revenue | 254.88M |
EBITDA | -14.83M |
Income | -18.59M |
Revenue Q/Q | -3.73% |
Revenue Y/Y | -1.21% |
Profit margin | -7.73% |
Oper. margin | -7.89% |
Gross margin | 43.2% |
EBIT margin | -7.89% |
EBITDA margin | -5.82% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeHeska stock price history
Heska stock forecast
Heska financial statements
Jun 2022 | 64.67M | -4.89M | -7.56% |
---|---|---|---|
Sep 2022 | 61.49M | -78K | -0.13% |
Dec 2022 | 66.33M | -3.85M | -5.8% |
Mar 2023 | 62.38M | -9.77M | -15.67% |
Jun 2022 | 586789000 | 169.50M | 28.89% |
---|---|---|---|
Sep 2022 | 570067000 | 162.16M | 28.45% |
Dec 2022 | 585816000 | 163.60M | 27.93% |
Mar 2023 | 592715000 | 175.04M | 29.53% |
Jun 2022 | 1.05M | -759K | 391K |
---|---|---|---|
Sep 2022 | -2.03M | -4.65M | -2.05M |
Dec 2022 | -3.16M | -514K | -2.12M |
Mar 2023 | -9.16M | -22.55M | -128K |
Heska alternative data
Aug 2023 | 808 |
---|---|
Sep 2023 | 808 |
Oct 2023 | 808 |
Nov 2023 | 808 |
Dec 2023 | 808 |
Jan 2024 | 808 |
Feb 2024 | 808 |
Mar 2024 | 808 |
Apr 2024 | 808 |
May 2024 | 808 |
Jun 2024 | 808 |
Jul 2024 | 808 |
Heska other data
Period | Buy | Sel |
---|---|---|
Mar 2022 | 0 | 663 |
Dec 2022 | 3440 | 0 |
Jan 2023 | 11018 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | WILSON KEVIN S. director, officer: CEO and Pres.. | Common Stock | 5,365 | $59.05 | $316,809 | ||
Purchase | WILSON KEVIN S. director, officer: CEO and Pres.. | Common Stock | 5,653 | $58.22 | $329,118 | ||
Purchase | WILSON KEVIN S. director, officer: CEO and Pres.. | Common Stock | 240 | $59.57 | $14,297 | ||
Purchase | WILSON KEVIN S. director, officer: CEO and Pres.. | Common Stock | 796 | $59.62 | $47,458 | ||
Purchase | WILSON KEVIN S. director, officer: CEO and Pres.. | Common Stock | 105 | $59.64 | $6,262 | ||
Purchase | WILSON KEVIN S. director, officer: CEO and Pres.. | Common Stock | 2,299 | $59.65 | $137,135 | ||
Option | WISNEWSKI NANCY officer: Chief Op.. | Incentive Stock Option (right to buy) | 10,000 | $8.55 | $85,500 | ||
Option | WISNEWSKI NANCY officer: Chief Op.. | Common Stock | 10,000 | $8.55 | $85,500 | ||
Option | WISNEWSKI NANCY officer: Chief Op.. | Performance Shares | 1,562 | N/A | N/A | ||
Option | WISNEWSKI NANCY officer: Chief Op.. | Common Stock | 1,562 | N/A | N/A |
Quarter | Transcript |
---|---|
Q4 2022 28 Feb 2023 | Q4 2022 Earnings Call Transcript |
Q3 2022 12 Nov 2022 | Q3 2022 Earnings Call Transcript |
Q2 2022 8 Aug 2022 | Q2 2022 Earnings Call Transcript |
Q1 2022 9 May 2022 | Q1 2022 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Kevin S. Wilson (1972) Chief Executive Officer, Pres & Director | $1,110,000 |
Ms. Catherine I. Grassman CPA (1976) Executive Vice President & Chief Financial Officer | $544,530 |
Mr. Steven M. Eyl (1966) Executive Vice President, Chief Commercial Officer & Pres of scil animal care company | $521,340 |
Dr. Nancy Wisnewski (1963) Executive Vice President & Chief Operating Officer | $474,300 |
-
When is Heska's next earnings date?
Unfortunately, Heska's (HSKA) next earnings date is currently unknown.
-
Does Heska pay dividends?
No, Heska does not pay dividends.
-
How much money does Heska make?
Heska has a market capitalization of 1.30B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.41% to 257.31M US dollars.
-
What is Heska's stock symbol?
Heska Corporation is traded on the NASDAQ under the ticker symbol "HSKA".
-
What is Heska's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Heska?
Shares of Heska can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Heska's key executives?
Heska's management team includes the following people:
- Mr. Kevin S. Wilson Chief Executive Officer, Pres & Director(age: 53, pay: $1,110,000)
- Ms. Catherine I. Grassman CPA Executive Vice President & Chief Financial Officer(age: 49, pay: $544,530)
- Mr. Steven M. Eyl Executive Vice President, Chief Commercial Officer & Pres of scil animal care company(age: 59, pay: $521,340)
- Dr. Nancy Wisnewski Executive Vice President & Chief Operating Officer(age: 62, pay: $474,300)
-
How many employees does Heska have?
As Jul 2024, Heska employs 808 workers.
-
When Heska went public?
Heska Corporation is publicly traded company for more then 28 years since IPO on 1 Jul 1997.
-
What is Heska's official website?
The official website for Heska is heska.com.
-
Where are Heska's headquarters?
Heska is headquartered at 3760 Rocky Mountain Avenue, Loveland, CO.
-
How can i contact Heska?
Heska's mailing address is 3760 Rocky Mountain Avenue, Loveland, CO and company can be reached via phone at +970 4937272.
Heska company profile:

Heska Corporation
heska.comNASDAQ
808
Medical - Devices
Healthcare
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
Loveland, CO 80538
CIK: 0001038133
ISIN: US42805E3062
CUSIP: 42805E306